ImmunityBio (NASDAQ:IBRX – Get Free Report) is one of 282 public companies in the “Biological products, except diagnostic” industry, but how does it contrast to its rivals? We will compare ImmunityBio to related businesses based on the strength of its valuation, dividends, risk, analyst recommendations, institutional ownership, earnings and profitability. Earnings & Valuation This table […]
ImmunityBio (NASDAQ:IBRX – Get Free Report) is one of 282 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare ImmunityBio to related businesses based on the strength of its earnings, profitability, institutional ownership, dividends, risk, valuation and analyst recommendations. Institutional & Insider Ownership 8.6% […]
ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report)’s stock price was down 6.7% during mid-day trading on Monday . The stock traded as low as $4.89 and last traded at $5.01. Approximately 597,618 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 3,979,879 shares. The stock had previously closed […]
ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report)’s stock price was down 6.7% during mid-day trading on Monday . The stock traded as low as $4.89 and last traded at $5.01. Approximately 597,618 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 3,979,879 shares. The stock had previously closed […]
ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) dropped 6.7% on Monday . The stock traded as low as $4.89 and last traded at $5.01. Approximately 597,618 shares were traded during trading, a decline of 85% from the average daily volume of 3,979,879 shares. The stock had previously closed at $5.37. Wall Street Analysts Forecast Growth […]